Ambion's First Molecular Test Adopted by the Blood Center

Ambion Diagnostics announced the adoption of its first molecular genetic test, Signature CF 2.0 ASR, by The Blood Center of Southeastern Wisconsin. The Signature CF 2.0 ASR, for the detection of mutations in the gene associated with cystic fibrosis, represents a new generation of molecular diagnostic tests that brings simplicity and speed to genetic testing.

ArriveNet (http://press.arrivenet.com/bus/article.php/604438.html)